1. Acyanotic congenital heart defects like ventricular septal defects (VSD), atrial septal defects (ASD), and atrioventricular septal defects involve left-to-right shunting that can cause pulmonary overcirculation and congestion over time.
2. During anesthesia for repairs of these defects, careful attention must be paid to balancing systemic and pulmonary vascular resistances to avoid increasing or decreasing the shunt. Inhalational induction is relatively contraindicated due to risk of shunt reversal and cyanosis.
3. Intravenous induction with ketamine or etomidate is preferred for acyanotic left-to-right shunt defects to gradually control hemodynamics
Wolff-Parkinson-White syndrome is a congenital heart condition caused by an abnormal accessory electrical pathway between the atria and ventricles. This pathway can lead to arrhythmias like atrial fibrillation or tachycardia that cause symptoms like palpitations, fainting, and blackouts. While sometimes the pathways disappear on their own, treatment options include catheter ablation to destroy the pathways or medications to prevent arrhythmias. The condition is diagnosed through ECG and affects about 1 in 100,000 people, most often diagnosed in childhood or adolescence.
Anesthesia for children with Congenital Heart Diseasecairo1957
This document provides an overview of congenital heart disease (CHD) in children, including:
- The incidence of CHD is 7-10 per 1000 live births, with some forms being more common in premature infants. The most common types are ventricular septal defects and atrial septal defects.
- CHD can be classified based on the direction of blood shunting (left-to-right or right-to-left), presence of mixing lesions, or obstructive lesions. Examples of different types of CHD are provided with diagrams.
- Management of CHD depends on whether the heart defect is uncorrected, partially corrected, or completely corrected. A multidisciplinary approach is needed and
CONGENITAL HEART DISEASE & ANAESTHESIA by Dr.Sravani VishnubhatlaDrSravaniVishnubhatl
1) Congenital heart defects are the most common birth defects, affecting 1 in 125 live births. They range from simple shunt lesions to complex defects involving multiple structures.
2) The anesthetic goals vary depending on the type of shunt (left-to-right vs right-to-left) and aim to balance systemic and pulmonary vascular resistances.
3) Preoperative evaluation and optimization is important. Regional techniques may be used when hemodynamically appropriate but general anesthesia allows better control of ventilation and hemodynamics for high risk surgery.
This document provides a case scenario of a 4-week-old male infant presenting with cyanosis after feeding or crying. On examination, the infant has purplish lips, hands and feet, a grade III/VI systolic murmur, and tests revealing low oxygen levels that increase slightly with oxygen. The document discusses possible diagnoses of congenital cyanotic heart disease such as tetralogy of Fallot and asks what the diagnosis could be. It then provides an overview of tetralogy of Fallot and its characteristics.
Approach to cyanotic congenital heart diseaseikramdr01
This document provides guidance on diagnosing cyanotic congenital heart disease through a practical clinical approach. It emphasizes the importance of suspecting heart disease in any child who does not clearly fit the initial diagnosis or has significant desaturation. Key signs to look for include cyanosis, differential pulse oximetry readings, and clues from chest X-ray and ECG. The approach involves classifying heart defects based on hemodynamics like pulmonary blood flow and systemic saturation. For neonates, focus is on duct-dependent lesions presenting with cyanosis or shock. Beyond the neonatal period, diagnosis involves assessing cyanosis and pulmonary congestion to identify lesions like left-to-right shunts, tetralogy of Fallot physiology,
Approach to a Child with Congenital Heart DiseseCSN Vittal
This document discusses congenital heart diseases (CHD), specifically ventricular septal defects (VSD). It begins by outlining the approach to diagnosing and classifying CHD. It then describes the different types of VSDs based on their anatomical location, including perimembranous, muscular, inlet, and supracristal defects. The clinical manifestations, physical exam findings, ECG patterns, chest x-ray appearances, and echocardiogram features of VSDs are discussed in detail.
Management of cyanotic congenital heart diseae3Sandip Gupta
1) The document discusses the management of various cyanotic congenital heart diseases that present in newborns including Tetralogy of Fallot (TOF), Transposition of the Great Arteries (TGA), Tricuspid Atresia (TA), Total Anomalous Pulmonary Venous Return (TAPVR), and Truncus Arteriosus.
2) It outlines the initial management of life-threatening presentations including shock, cyanosis, and heart failure as well as treatments for cyanosis including prostaglandin E1.
3) The long-term medical and surgical management strategies for each condition are described, including palliative procedures and definitive repairs. Shunt operations,
Wolff-Parkinson-White syndrome is a congenital heart condition caused by an abnormal accessory electrical pathway between the atria and ventricles. This pathway can lead to arrhythmias like atrial fibrillation or tachycardia that cause symptoms like palpitations, fainting, and blackouts. While sometimes the pathways disappear on their own, treatment options include catheter ablation to destroy the pathways or medications to prevent arrhythmias. The condition is diagnosed through ECG and affects about 1 in 100,000 people, most often diagnosed in childhood or adolescence.
Anesthesia for children with Congenital Heart Diseasecairo1957
This document provides an overview of congenital heart disease (CHD) in children, including:
- The incidence of CHD is 7-10 per 1000 live births, with some forms being more common in premature infants. The most common types are ventricular septal defects and atrial septal defects.
- CHD can be classified based on the direction of blood shunting (left-to-right or right-to-left), presence of mixing lesions, or obstructive lesions. Examples of different types of CHD are provided with diagrams.
- Management of CHD depends on whether the heart defect is uncorrected, partially corrected, or completely corrected. A multidisciplinary approach is needed and
CONGENITAL HEART DISEASE & ANAESTHESIA by Dr.Sravani VishnubhatlaDrSravaniVishnubhatl
1) Congenital heart defects are the most common birth defects, affecting 1 in 125 live births. They range from simple shunt lesions to complex defects involving multiple structures.
2) The anesthetic goals vary depending on the type of shunt (left-to-right vs right-to-left) and aim to balance systemic and pulmonary vascular resistances.
3) Preoperative evaluation and optimization is important. Regional techniques may be used when hemodynamically appropriate but general anesthesia allows better control of ventilation and hemodynamics for high risk surgery.
This document provides a case scenario of a 4-week-old male infant presenting with cyanosis after feeding or crying. On examination, the infant has purplish lips, hands and feet, a grade III/VI systolic murmur, and tests revealing low oxygen levels that increase slightly with oxygen. The document discusses possible diagnoses of congenital cyanotic heart disease such as tetralogy of Fallot and asks what the diagnosis could be. It then provides an overview of tetralogy of Fallot and its characteristics.
Approach to cyanotic congenital heart diseaseikramdr01
This document provides guidance on diagnosing cyanotic congenital heart disease through a practical clinical approach. It emphasizes the importance of suspecting heart disease in any child who does not clearly fit the initial diagnosis or has significant desaturation. Key signs to look for include cyanosis, differential pulse oximetry readings, and clues from chest X-ray and ECG. The approach involves classifying heart defects based on hemodynamics like pulmonary blood flow and systemic saturation. For neonates, focus is on duct-dependent lesions presenting with cyanosis or shock. Beyond the neonatal period, diagnosis involves assessing cyanosis and pulmonary congestion to identify lesions like left-to-right shunts, tetralogy of Fallot physiology,
Approach to a Child with Congenital Heart DiseseCSN Vittal
This document discusses congenital heart diseases (CHD), specifically ventricular septal defects (VSD). It begins by outlining the approach to diagnosing and classifying CHD. It then describes the different types of VSDs based on their anatomical location, including perimembranous, muscular, inlet, and supracristal defects. The clinical manifestations, physical exam findings, ECG patterns, chest x-ray appearances, and echocardiogram features of VSDs are discussed in detail.
Management of cyanotic congenital heart diseae3Sandip Gupta
1) The document discusses the management of various cyanotic congenital heart diseases that present in newborns including Tetralogy of Fallot (TOF), Transposition of the Great Arteries (TGA), Tricuspid Atresia (TA), Total Anomalous Pulmonary Venous Return (TAPVR), and Truncus Arteriosus.
2) It outlines the initial management of life-threatening presentations including shock, cyanosis, and heart failure as well as treatments for cyanosis including prostaglandin E1.
3) The long-term medical and surgical management strategies for each condition are described, including palliative procedures and definitive repairs. Shunt operations,
Anesthesia for non cardiac surgery in adults with Congenital Heart DiseaseAnkita Patni
This document discusses anaesthetic management considerations for adults with congenital heart disease undergoing non-cardiac surgery. It outlines common congenital heart defects seen in adults and their long-term consequences, including pulmonary hypertension, bleeding/thrombosis risk, heart failure, and dysrhythmias. It provides guidance on preoperative evaluation, intraoperative monitoring tailored to specific defects, management strategies for defects like Fontan circulation, and postoperative care focused on preventing complications in the ICU.
This document discusses Eisenmenger syndrome, a condition where pulmonary hypertension develops due to increased blood flow through defects between the systemic and pulmonary circulations. It provides details on causes, clinical features, pathology findings, and treatments. Key points include:
- Eisenmenger syndrome is caused by defects like VSDs, ASDs, and PDA that allow high blood flow to the lungs and cause pulmonary hypertension over time.
- Common causes of death include hemoptysis from pulmonary artery ruptures, heart failure, and complications from attempted defect repair surgery.
- Pathological findings show thickened pulmonary arteries that resemble the fetal pattern and contribute to high pulmonary vascular resistance.
- Medical treatments are generally ineffective once int
A 67-year-old man presents to the emergency department with sudden onset of chest pain and shortness of breath. On examination, he has signs of pulmonary edema and a loud heart murmur, and has a history of a recent heart attack. The most appropriate initial management is to provide standard treatment for pulmonary edema and consider the need for urgent valve replacement surgery given the acute presentation in the setting of known valvular heart disease.
This document discusses the perinatal management of a newborn with congenital heart disease. Key details include:
- The newborn was delivered via c-section, needed intubation, and had low oxygen saturation levels. Echocardiogram revealed a congenital heart defect.
- Risk factors and causes of congenital heart defects are discussed, including maternal conditions, genetics, infections, and drugs.
- Screening methods like pulse oximetry can help identify defects, though timing and factors can impact results. Criteria for positive screens are outlined.
- Initial management may include supportive care, antibiotics, prostaglandin E1, and referral for cardiac procedures or surgery depending on the defect.
This document provides information about critical congenital heart diseases (CCHD). It discusses the importance of CCHD as heart defects are a leading cause of birth defect deaths. Approximately 1 in 4 babies born with a heart defect has a CCHD, which often requires surgery or procedures in the first year of life. The document outlines the primary and secondary targets for CCHD screening, including conditions like hypoplastic left heart syndrome and transposition of the great arteries. Risk factors for CCHD can include genetic conditions and environmental exposures. Timely screening and treatment of CCHDs is important to prevent disability and death in newborns.
This document summarizes the diagnosis and management of critical congenital heart disease in neonates. It discusses prenatal evaluation, initial evaluation and stabilization, confirmation of diagnosis, preoperative evaluation of other organ systems, and lesion-specific surgical management. Key lesions discussed in detail include hypoplastic left heart syndrome, transposition of the great arteries, and total anomalous pulmonary venous connection.
This document discusses anaesthetic considerations for closed heart procedures including those correcting lesions like patent ductus arteriosus and coarctation of the aorta, as well as palliative procedures like banding of the pulmonary artery. It covers the relevant anatomy, pathophysiology, clinical presentation, diagnosis and management of these conditions. Specifically, it emphasizes the importance of invasive hemodynamic monitoring during surgery due to risks of hypotension and paraplegia from spinal cord ischemia. Careful blood pressure control is needed during and after the procedures.
This document discusses cyanotic congenital heart disease (CCHD), which is defined as a cardiovascular birth defect that results in systemic arterial desaturation due to a right-to-left shunt. CCHDs can be classified based on pulmonary blood flow as having reduced, increased, or near normal flow. Common types of CCHDs with reduced pulmonary blood flow include tetralogy of Fallot and pulmonary atresia. CCHDs with increased pulmonary blood flow can present with features of congestive heart failure. The clinical approach to CCHDs involves delineating the anatomical and physiological abnormalities through assessment of anatomy, pulmonary circulation, systemic circulation, and ventricular function.
ECG- Atrial Fibrillation, CXR-P/A view-Cardiomegaly,
Echocardiogram-severe mitral stenosis with severe MR with
moderate pulmonary hypertension. Patient underwent MVR and
she is doing well.
This document discusses the management of cyanotic patients. It covers several topics:
1. Causes of cyanosis including cardiac and non-cardiac causes such as lung diseases and neurological issues.
2. Evaluation of cyanotic newborns including detecting cyanosis and checking oxygen saturation levels.
3. Complications of cyanosis such as cyanotic spells, neurological complications, erythrocytosis, and anemia. Management of these complications is also discussed.
This document provides an overview of Eisenmenger syndrome, including its definition, causes, classifications, modes of presentation, and treatment approaches. Some key points include:
- Eisenmenger syndrome is defined as irreversible pulmonary hypertension caused by uncorrected congenital shunts between the systemic and pulmonary circulations.
- It can be caused by defects such as ventricular septal defects, atrial septal defects, and patent ductus arteriosus. Its presentation and progression depends on factors like the size and location of the defect.
- Patients typically experience symptoms like dyspnea, cyanosis, hyperviscosity, and right heart failure. Complications can include hemoptysis, stroke, and cerebral abs
This document provides an overview of medical management in patients with Eisenmenger syndrome. It discusses:
1. The history and pathophysiology of Eisenmenger syndrome, which develops when a pre-existing left-to-right shunt reverses direction due to high pulmonary vascular resistance, causing hypoxemia.
2. The clinical presentation and complications of Eisenmenger syndrome including pulmonary hypertension, heart failure, erythrocytosis, bleeding, cholelithiasis and others.
3. Evaluations including echocardiogram, cardiac catheterization and imaging studies to characterize the underlying anatomy and assess pulmonary pressures and resistance.
4. Medical management focuses on pulmonary vasodilators like
This document provides an overview of cyanotic heart disease in newborns. It discusses the causes, types, and approach to evaluating and managing cyanosis. Key points include:
- Cyanosis is a bluish discoloration of the skin from low oxygen levels in the blood. It is detectable at oxygen saturations below 85%.
- Cardiac causes of cyanosis include decreased or increased pulmonary blood flow from conditions like tetralogy of Fallot or transposition of the great arteries.
- Evaluation involves history, physical exam, chest X-ray, ECG, pulse oximetry, blood gases and hyperoxic challenge test, and echocardiogram.
- Management focuses on maintaining ductus arter
This document discusses congenital heart diseases (CHDs). It begins by describing fetal circulation and the contents include fetal circulation, incidence and classification of CHDs, hemodynamics of common CHDs like atrial septal defect (ASD), ventricular septal defect (VSD), patent ductus arteriosus (PDA), tetralogy of fallot, and transposition of the great vessels. For each condition, the document discusses clinical presentation, diagnosis, and management. The classification divides CHDs into acyanotic and cyanotic types. The document provides an overview of several major CHDs, their presentations, and treatment approaches.
Anesthesia For Children With Congenital Heart Disease1Ahmed Shalabi
This document discusses children with congenital heart disease and provides information on:
1. The incidence of congenital heart disease is 7 to 10 per 1000 live births, with certain populations having higher rates.
2. Congenital heart disease can range from simple defects like atrial septal defects to complex conditions like hypoplastic left heart syndrome.
3. Proper preoperative evaluation is important for anesthetic planning and involves understanding the child's specific cardiac anatomy and physiology.
This document provides an overview of the classification, pathophysiology, preoperative evaluation, and anesthetic management considerations for patients undergoing surgery with congenital heart defects such as atrial septal defects (ASD) and ventricular septal defects (VSD). It discusses the pathophysiology of left-to-right and right-to-left shunting, preoperative assessment including history, examination, investigations, and risk factors. It also outlines goals and techniques for anesthesia including bubble avoidance, optimizing oxygen delivery and ventilation, and avoiding hypovolemia and increases in left-to-right shunting. Specific considerations for inhalational and intravenous induction agents, central neuraxial blockade, pregnancy, and Eisenmenger
This document discusses neonatal cardiac failure, including the pathophysiology of atrioventricular septal defect. It notes that the neonatal myocardium is anatomically different from the mature heart, with less organized myofibrils and contractile efficiency. This makes the neonatal heart more dependent on compensatory mechanisms like neurohormonal activation and the Frank-Starling response. Medical management aims to reduce afterload and preload on the heart through diuretics and ACE inhibitors while providing respiratory support. Surgical intervention may be needed to correct underlying structural defects.
Anesthesia And Congenital Heart DiseaseAhmed Shalabi
This document summarizes adult congenital heart disease and considerations for anesthesia management. It discusses that:
1) Congenital heart diseases are increasingly common as more children with complex defects now survive into adulthood.
2) Adults with CHD can be categorized as those with complete repair, partial/palliative repair, or no operation.
3) Five factors influence perioperative risk - pulmonary hypertension, cyanosis, reoperation, arrhythmias, and ventricular dysfunction.
This document discusses congenital heart disease, including cyanotic heart lesions such as transposition of the great arteries and tetralogy of Fallot. For transposition of the great arteries, the aorta arises from the right ventricle and pulmonary artery from the left, requiring a mixing defect like VSD to allow blood flow. Clinical symptoms depend on anatomy and range from profound hypoxia without mixing to cyanosis with mixing. Management includes prostaglandins and atrial septostomy. For tetralogy of Fallot, the four defects cause right ventricular outflow obstruction, leading to cyanosis during spells that can be treated with positioning, sedation, and propranolol. Later treatments include palliative shunts
Eisenmenger syndrome is pulmonary hypertension caused by an uncorrected heart defect that results in a reversed or bidirectional blood flow. It is diagnosed based on findings of cyanosis, clubbing, hypoxemia and signs of pulmonary hypertension and right heart strain. Management focuses on avoiding destabilizing factors and treating complications conservatively as interventions carry high risk. Pregnancy is absolutely contraindicated due to high maternal mortality risk.
This document provides information on various cyanotic heart lesions including Tetralogy of Fallot, Transposition of the Great Arteries, Tricuspid Atresia, Ebstein's Anomaly and Total Anomalous Pulmonary Venous Return. It describes the anatomy, clinical features, diagnosis and management of these conditions. Key cyanotic heart lesions are characterized by mixing of oxygenated and deoxygenated blood resulting in central cyanosis.
The document discusses pulmonary hypertension and the pulmonary circulation. It covers:
1) The anatomy of the pulmonary circulation including the pulmonary arterial and bronchial circulations.
2) The physiology of the low pressure pulmonary system and how blood flow is regulated.
3) The classifications, causes, signs and symptoms, and imaging manifestations of various types of pulmonary hypertension including pulmonary arterial hypertension, pulmonary hypertension due to lung/hypoxic diseases, chronic thromboembolic pulmonary hypertension, and pulmonary hypertension related to left heart disease.
4) The pathophysiology and histopathological changes seen in different forms of pulmonary hypertension.
Anesthesia for non cardiac surgery in adults with Congenital Heart DiseaseAnkita Patni
This document discusses anaesthetic management considerations for adults with congenital heart disease undergoing non-cardiac surgery. It outlines common congenital heart defects seen in adults and their long-term consequences, including pulmonary hypertension, bleeding/thrombosis risk, heart failure, and dysrhythmias. It provides guidance on preoperative evaluation, intraoperative monitoring tailored to specific defects, management strategies for defects like Fontan circulation, and postoperative care focused on preventing complications in the ICU.
This document discusses Eisenmenger syndrome, a condition where pulmonary hypertension develops due to increased blood flow through defects between the systemic and pulmonary circulations. It provides details on causes, clinical features, pathology findings, and treatments. Key points include:
- Eisenmenger syndrome is caused by defects like VSDs, ASDs, and PDA that allow high blood flow to the lungs and cause pulmonary hypertension over time.
- Common causes of death include hemoptysis from pulmonary artery ruptures, heart failure, and complications from attempted defect repair surgery.
- Pathological findings show thickened pulmonary arteries that resemble the fetal pattern and contribute to high pulmonary vascular resistance.
- Medical treatments are generally ineffective once int
A 67-year-old man presents to the emergency department with sudden onset of chest pain and shortness of breath. On examination, he has signs of pulmonary edema and a loud heart murmur, and has a history of a recent heart attack. The most appropriate initial management is to provide standard treatment for pulmonary edema and consider the need for urgent valve replacement surgery given the acute presentation in the setting of known valvular heart disease.
This document discusses the perinatal management of a newborn with congenital heart disease. Key details include:
- The newborn was delivered via c-section, needed intubation, and had low oxygen saturation levels. Echocardiogram revealed a congenital heart defect.
- Risk factors and causes of congenital heart defects are discussed, including maternal conditions, genetics, infections, and drugs.
- Screening methods like pulse oximetry can help identify defects, though timing and factors can impact results. Criteria for positive screens are outlined.
- Initial management may include supportive care, antibiotics, prostaglandin E1, and referral for cardiac procedures or surgery depending on the defect.
This document provides information about critical congenital heart diseases (CCHD). It discusses the importance of CCHD as heart defects are a leading cause of birth defect deaths. Approximately 1 in 4 babies born with a heart defect has a CCHD, which often requires surgery or procedures in the first year of life. The document outlines the primary and secondary targets for CCHD screening, including conditions like hypoplastic left heart syndrome and transposition of the great arteries. Risk factors for CCHD can include genetic conditions and environmental exposures. Timely screening and treatment of CCHDs is important to prevent disability and death in newborns.
This document summarizes the diagnosis and management of critical congenital heart disease in neonates. It discusses prenatal evaluation, initial evaluation and stabilization, confirmation of diagnosis, preoperative evaluation of other organ systems, and lesion-specific surgical management. Key lesions discussed in detail include hypoplastic left heart syndrome, transposition of the great arteries, and total anomalous pulmonary venous connection.
This document discusses anaesthetic considerations for closed heart procedures including those correcting lesions like patent ductus arteriosus and coarctation of the aorta, as well as palliative procedures like banding of the pulmonary artery. It covers the relevant anatomy, pathophysiology, clinical presentation, diagnosis and management of these conditions. Specifically, it emphasizes the importance of invasive hemodynamic monitoring during surgery due to risks of hypotension and paraplegia from spinal cord ischemia. Careful blood pressure control is needed during and after the procedures.
This document discusses cyanotic congenital heart disease (CCHD), which is defined as a cardiovascular birth defect that results in systemic arterial desaturation due to a right-to-left shunt. CCHDs can be classified based on pulmonary blood flow as having reduced, increased, or near normal flow. Common types of CCHDs with reduced pulmonary blood flow include tetralogy of Fallot and pulmonary atresia. CCHDs with increased pulmonary blood flow can present with features of congestive heart failure. The clinical approach to CCHDs involves delineating the anatomical and physiological abnormalities through assessment of anatomy, pulmonary circulation, systemic circulation, and ventricular function.
ECG- Atrial Fibrillation, CXR-P/A view-Cardiomegaly,
Echocardiogram-severe mitral stenosis with severe MR with
moderate pulmonary hypertension. Patient underwent MVR and
she is doing well.
This document discusses the management of cyanotic patients. It covers several topics:
1. Causes of cyanosis including cardiac and non-cardiac causes such as lung diseases and neurological issues.
2. Evaluation of cyanotic newborns including detecting cyanosis and checking oxygen saturation levels.
3. Complications of cyanosis such as cyanotic spells, neurological complications, erythrocytosis, and anemia. Management of these complications is also discussed.
This document provides an overview of Eisenmenger syndrome, including its definition, causes, classifications, modes of presentation, and treatment approaches. Some key points include:
- Eisenmenger syndrome is defined as irreversible pulmonary hypertension caused by uncorrected congenital shunts between the systemic and pulmonary circulations.
- It can be caused by defects such as ventricular septal defects, atrial septal defects, and patent ductus arteriosus. Its presentation and progression depends on factors like the size and location of the defect.
- Patients typically experience symptoms like dyspnea, cyanosis, hyperviscosity, and right heart failure. Complications can include hemoptysis, stroke, and cerebral abs
This document provides an overview of medical management in patients with Eisenmenger syndrome. It discusses:
1. The history and pathophysiology of Eisenmenger syndrome, which develops when a pre-existing left-to-right shunt reverses direction due to high pulmonary vascular resistance, causing hypoxemia.
2. The clinical presentation and complications of Eisenmenger syndrome including pulmonary hypertension, heart failure, erythrocytosis, bleeding, cholelithiasis and others.
3. Evaluations including echocardiogram, cardiac catheterization and imaging studies to characterize the underlying anatomy and assess pulmonary pressures and resistance.
4. Medical management focuses on pulmonary vasodilators like
This document provides an overview of cyanotic heart disease in newborns. It discusses the causes, types, and approach to evaluating and managing cyanosis. Key points include:
- Cyanosis is a bluish discoloration of the skin from low oxygen levels in the blood. It is detectable at oxygen saturations below 85%.
- Cardiac causes of cyanosis include decreased or increased pulmonary blood flow from conditions like tetralogy of Fallot or transposition of the great arteries.
- Evaluation involves history, physical exam, chest X-ray, ECG, pulse oximetry, blood gases and hyperoxic challenge test, and echocardiogram.
- Management focuses on maintaining ductus arter
This document discusses congenital heart diseases (CHDs). It begins by describing fetal circulation and the contents include fetal circulation, incidence and classification of CHDs, hemodynamics of common CHDs like atrial septal defect (ASD), ventricular septal defect (VSD), patent ductus arteriosus (PDA), tetralogy of fallot, and transposition of the great vessels. For each condition, the document discusses clinical presentation, diagnosis, and management. The classification divides CHDs into acyanotic and cyanotic types. The document provides an overview of several major CHDs, their presentations, and treatment approaches.
Anesthesia For Children With Congenital Heart Disease1Ahmed Shalabi
This document discusses children with congenital heart disease and provides information on:
1. The incidence of congenital heart disease is 7 to 10 per 1000 live births, with certain populations having higher rates.
2. Congenital heart disease can range from simple defects like atrial septal defects to complex conditions like hypoplastic left heart syndrome.
3. Proper preoperative evaluation is important for anesthetic planning and involves understanding the child's specific cardiac anatomy and physiology.
This document provides an overview of the classification, pathophysiology, preoperative evaluation, and anesthetic management considerations for patients undergoing surgery with congenital heart defects such as atrial septal defects (ASD) and ventricular septal defects (VSD). It discusses the pathophysiology of left-to-right and right-to-left shunting, preoperative assessment including history, examination, investigations, and risk factors. It also outlines goals and techniques for anesthesia including bubble avoidance, optimizing oxygen delivery and ventilation, and avoiding hypovolemia and increases in left-to-right shunting. Specific considerations for inhalational and intravenous induction agents, central neuraxial blockade, pregnancy, and Eisenmenger
This document discusses neonatal cardiac failure, including the pathophysiology of atrioventricular septal defect. It notes that the neonatal myocardium is anatomically different from the mature heart, with less organized myofibrils and contractile efficiency. This makes the neonatal heart more dependent on compensatory mechanisms like neurohormonal activation and the Frank-Starling response. Medical management aims to reduce afterload and preload on the heart through diuretics and ACE inhibitors while providing respiratory support. Surgical intervention may be needed to correct underlying structural defects.
Anesthesia And Congenital Heart DiseaseAhmed Shalabi
This document summarizes adult congenital heart disease and considerations for anesthesia management. It discusses that:
1) Congenital heart diseases are increasingly common as more children with complex defects now survive into adulthood.
2) Adults with CHD can be categorized as those with complete repair, partial/palliative repair, or no operation.
3) Five factors influence perioperative risk - pulmonary hypertension, cyanosis, reoperation, arrhythmias, and ventricular dysfunction.
This document discusses congenital heart disease, including cyanotic heart lesions such as transposition of the great arteries and tetralogy of Fallot. For transposition of the great arteries, the aorta arises from the right ventricle and pulmonary artery from the left, requiring a mixing defect like VSD to allow blood flow. Clinical symptoms depend on anatomy and range from profound hypoxia without mixing to cyanosis with mixing. Management includes prostaglandins and atrial septostomy. For tetralogy of Fallot, the four defects cause right ventricular outflow obstruction, leading to cyanosis during spells that can be treated with positioning, sedation, and propranolol. Later treatments include palliative shunts
Eisenmenger syndrome is pulmonary hypertension caused by an uncorrected heart defect that results in a reversed or bidirectional blood flow. It is diagnosed based on findings of cyanosis, clubbing, hypoxemia and signs of pulmonary hypertension and right heart strain. Management focuses on avoiding destabilizing factors and treating complications conservatively as interventions carry high risk. Pregnancy is absolutely contraindicated due to high maternal mortality risk.
This document provides information on various cyanotic heart lesions including Tetralogy of Fallot, Transposition of the Great Arteries, Tricuspid Atresia, Ebstein's Anomaly and Total Anomalous Pulmonary Venous Return. It describes the anatomy, clinical features, diagnosis and management of these conditions. Key cyanotic heart lesions are characterized by mixing of oxygenated and deoxygenated blood resulting in central cyanosis.
The document discusses pulmonary hypertension and the pulmonary circulation. It covers:
1) The anatomy of the pulmonary circulation including the pulmonary arterial and bronchial circulations.
2) The physiology of the low pressure pulmonary system and how blood flow is regulated.
3) The classifications, causes, signs and symptoms, and imaging manifestations of various types of pulmonary hypertension including pulmonary arterial hypertension, pulmonary hypertension due to lung/hypoxic diseases, chronic thromboembolic pulmonary hypertension, and pulmonary hypertension related to left heart disease.
4) The pathophysiology and histopathological changes seen in different forms of pulmonary hypertension.
This document provides information on congenital heart disease, including definitions, classifications, and details on specific conditions. It defines congenital heart disease and notes its prevalence of about 1% of live births. It classifies heart defects into left-to-right shunt lesions, right to left shunt lesions, and obstructive lesions. Details are given on specific conditions including atrial septal defect, ventricular septal defect, and patent ductus arteriosus. For each, the document describes hemodynamics, clinical findings, diagnosis, and treatment. Echocardiography is highlighted as the primary diagnostic tool for congenital heart disease.
This document summarizes cyanotic congenital heart disease. It describes:
1) The classification of congenital heart diseases into left to right shunts, right to left shunts, and obstructive lesions.
2) The causes of cyanosis including right to left shunting defects like tetralogy of Fallot, transposition of the great arteries, truncus arteriosus, and total anomalous pulmonary venous return.
3) The clinical presentation, evaluation, and management of cyanotic spells in tetralogy of Fallot patients and the surgical repairs for various cyanotic congenital heart defects.
This document discusses the classification and pathophysiology of congenital heart disease. It covers the different types of shunts including simple shunts with increased pulmonary blood flow, complex shunts with associated obstructive lesions, and the physiologic classification of acyanotic and cyanotic defects. Key aspects of anesthetic management are summarized, including preoperative evaluation and optimization of pulmonary and systemic vascular resistances to balance blood flow depending on the type of shunting present. Choice of induction agents, inhalational anesthetics, and postoperative care are also addressed.
This document discusses congenital heart diseases, beginning with a review of fetal circulation and how it transitions after birth. It then classifies common acyanotic and cyanotic congenital heart diseases. Ventricular septal defect, patent ductus arteriosus, and coarctation of the aorta are discussed in more detail, including their pathophysiology, clinical presentation, diagnosis, and management principles. The objective is to revise fetal circulation, classify congenital heart diseases, and discuss common types and their clinical approach.
Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease, occurring in approximately 1 in 3,000 live births. It involves four abnormalities - a ventricular septal defect, right ventricular outflow tract obstruction, right ventricular hypertrophy, and overriding of the aorta. Without surgical repair, only 10% of patients survive beyond 20 years of age. Clinical manifestations include cyanosis, clubbing of the fingers and toes, and hypoxic spells in infants. Diagnosis is made through echocardiography, chest x-ray, and cardiac catheterization. Treatment involves palliative shunt procedures for infants or complete repair surgery to close the ventricular septal defect and widen the right ventricular
Acyanotic Congenital Heart Diseases;
1. Left-to-right shunts
a. Ventricular Septal Defect(VSD)
b. Atrial Septal Defect(ASD)
c. Patent Ductus Arteriosus(PDA)
d. Atrioventricular Septal Defect(AVSD)
e. Aortopulmonary window
* Eisenmenger Syndrome – The shunt becomes right-to-left
2. Left-sided obstructive lesions
a. Coarctation of the Aorta(COA)
b. Congenital Aortic Stenosis
c. Mitral Stenosis
d. Interrupted Aortic Arch
Cyanotic Congenital Heart Diseases;
1. Right-to-left shunts
a. Tetralogy of Fallot
b. Pulmonary stenosis
c. Pulmonary atresia
d. Tricuspid atresia
e. Ebstein’s anomaly
2. Complete mixed lesions
a. Transposition of the great vessels
b. Double outlet right ventricle(DORV)
c. Total anomalous pulmonary venous return
d. Truncus arteriosus
e. Hypoplastic left heart syndrome
Adult Congenital Heart Disease can affect over 1 million adults in the US. Common conditions include Atrial Septal Defects, Ventricular Septal Defects, Patent Ductus Arteriosus, Bicuspid Aortic Valve, Coarctation of the Aorta, Tetralogy of Fallot, and Transposition of the Great Arteries. Clinical presentation and treatment depends on the specific condition and degree of severity. Long term monitoring is important for complications. Pregnancy can also pose additional risks for some congenital heart conditions.
This document provides an overview of congenital heart diseases, including:
1) It discusses the fetal circulation and transitional circulation that occurs after birth when ducts and shunts close.
2) Common congenital heart diseases are classified as acyanotic or cyanotic and examples like VSD, PDA, coarctation, Tetralogy of Fallot are discussed.
3) The epidemiology, pathophysiology, clinical presentation, investigations and general management principles of congenital heart diseases are outlined. Detailed descriptions are provided for VSD, PDA, coarctation and Tetralogy of Fallot.
1. Congenital cyanotic heart disease refers to heart defects present at birth that result in low oxygen levels in the blood. They are classified as those with increased or decreased blood flow to the lungs.
2. Common types with increased pulmonary blood flow include persistent truncus arteriosus and transposition of the great arteries (TGA). Common types with decreased pulmonary blood flow include tricuspid atresia and pulmonary atresia with intact ventricular septum.
3. TGA accounts for 5-7% of congenital heart defects. It involves the aorta originating from the right ventricle and the pulmonary artery originating from the left ventricle. It requires mixing of blood between the pulmonary and systemic
This document provides an overview of pulmonary hypertension (PH), including its history, clinical findings, investigations, classification, pathophysiology, and management. Some key points:
- PH can be caused by various underlying conditions and diseases. A thorough workup is needed to determine the specific type and cause.
- Common presenting symptoms are dyspnea and fatigue. Physical exam may reveal signs of right heart failure as disease progresses.
- Initial screening tests include echocardiogram, ECG, CXR. Right heart catheterization is the gold standard for diagnosis and assessing severity.
- PH is classified into 5 types based on underlying pathophysiology. The main types are PAH, PH related to lung/
1. Mitral stenosis is most commonly caused by rheumatic fever and results in thickening and calcification of the mitral valve, reducing the valve orifice area and obstructing blood flow from the left atrium to ventricle.
2. The pathophysiology involves elevated left atrial pressure, pulmonary hypertension, and reduced cardiac output. Symptoms range from easy fatigability to pulmonary edema.
3. Physical exam findings include an opening snap, rumbling diastolic murmur, and signs of right heart failure in severe cases. Severity is graded based on orifice area, pulmonary artery pressure, and NYHA functional
This document provides information on various congenital heart defects including patent ductus arteriosus (PDA), atrial septal defect (ASD), ventricular septal defect (VSD), and tetralogy of Fallot. It describes the anatomy and physiology of each condition, their signs and symptoms, diagnostic testing, potential complications, and treatment options. The key points are: PDA, ASD, and VSD can cause left-to-right or right-to-left blood shunts depending on pulmonary pressures. Tetralogy of Fallot is characterized by four defects that cause deoxygenated blood to mix with oxygenated blood, leading to cyanosis. Surgical closure of defects or transcatheter
This document provides information on congestive cardiac failure (CCF), including its definition, pathophysiology, clinical features, investigations, and management. CCF occurs when the heart muscle is weakened and cannot maintain adequate cardiac output. The pathophysiology involves changes in preload, afterload, and contractility that decrease cardiac output. Compensatory mechanisms initially help but later worsen symptoms. Clinically, CCF presents with dyspnea, edema, elevated JVP, hepatomegaly, and other signs. Investigations include BNP, ECG, echocardiogram. Management focuses on treating the underlying cause, reducing preload/afterload, and improving contractility. Diuretics, ACE inhibitors, beta
Educative power-point presentation for students in paediatrics, paediatric critical care, neonatology, And trainees or fellows in paediatric critical care
This document discusses pulmonary embolism (PE), including its risk factors, pathophysiology, diagnosis, and management. It notes that PE is a leading cause of cardiovascular death and hospital mortality. Rudolf Virchow identified three main factors that contribute to venous thrombosis and PE: venous stasis, hypercoagulability of blood, and endothelial injury. The pathophysiology of PE involves increased pulmonary vascular resistance and right heart strain or failure. Diagnosis involves assessing clinical risk factors, biomarkers like troponin and BNP, imaging tests like CTPA, and echocardiography. PE is classified as massive, submassive, or low-risk depending on the presence of hypotension and right heart dysfunction. Management involves he
This document discusses valvular heart disease, focusing on aortic stenosis, mitral stenosis, aortic regurgitation, and mitral regurgitation. It covers the etiology, pathophysiology, presentation, evaluation, and management of each condition. For aortic and mitral stenosis, the goals are to recognize symptoms of severe disease and identify patients who need valve replacement. For regurgitant lesions, treatment focuses on supporting cardiac function medically until symptoms appear or structural deterioration occurs, then referring for surgical intervention. Echocardiography plays a key role in diagnosing severity and monitoring progression.
Similar to Pediatric anesthesia and cardiac problems 1 (20)
Selective alpha1 blockers are Prazosin, Terazosin, Doxazosin, Tamsulosin and Silodosin majorly used to treat BPH, also hypertension, PTSD, Raynaud's phenomenon, CHF
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...Jim Jacob Roy
In this presentation , SBP ( spontaneous bacterial peritonitis ) , which is a common complication in patients with cirrhosis and ascites is described in detail.
The reference for this presentation is Sleisenger and Fordtran's Gastrointestinal and Liver Disease Textbook ( 11th edition ).
Allopurinol, a uric acid synthesis inhibitor acts by inhibiting Xanthine oxidase competitively as well as non- competitively, Whereas Oxypurinol is a non-competitive inhibitor of xanthine oxidase.
Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or at least to improve the clinical status of a patient.
One of the basic concepts of gene therapy is to transform viruses into genetic shuttles, which will deliver the gene of interest into the target cells.
Safe methods have been devised to do this, using several viral and non-viral vectors.
In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The biggest hurdle faced by medical research in gene therapy is the availability of effective gene-carrying vectors that meet all of the following criteria:
Protection of transgene or genetic cargo from degradative action of systemic and endonucleases,
Delivery of genetic material to the target site, i.e., either cell cytoplasm or nucleus,
Low potential of triggering unwanted immune responses or genotoxicity,
Economical and feasible availability for patients .
Viruses are naturally evolved vehicles that efficiently transfer their genes into host cells.
Choice of viral vector is dependent on gene transfer efficiency, capacity to carry foreign genes, toxicity, stability, immune responses towards viral antigens and potential viral recombination.
There are a wide variety of vectors used to deliver DNA or oligo nucleotides into mammalian cells, either in vitro or in vivo.
The most common vector system based on retroviruses, adenoviruses, herpes simplex viruses, adeno associated viruses.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Can Traditional Chinese Medicine Treat Blocked Fallopian Tubes.pptxFFragrant
There are many traditional Chinese medicine therapies to treat blocked fallopian tubes. And herbal medicine Fuyan Pill is one of the more effective choices.
Storyboard on Acne-Innovative Learning-M. pharm. (2nd sem.) CosmeticsMuskanShingari
Acne is a common skin condition that occurs when hair follicles become clogged with oil and dead skin cells. It typically manifests as pimples, blackheads, or whiteheads, often on the face, chest, shoulders, or back. Acne can range from mild to severe and may cause emotional distress and scarring in some cases.
**Causes:**
1. **Excess Oil Production:** Hormonal changes during adolescence or certain times in adulthood can increase sebum (oil) production, leading to clogged pores.
2. **Clogged Pores:** When dead skin cells and oil block hair follicles, bacteria (usually Propionibacterium acnes) can thrive, causing inflammation and acne lesions.
3. **Hormonal Factors:** Fluctuations in hormone levels, such as during puberty, menstrual cycles, pregnancy, or certain medical conditions, can contribute to acne.
4. **Genetics:** A family history of acne can increase the likelihood of developing the condition.
**Types of Acne:**
- **Whiteheads:** Closed plugged pores.
- **Blackheads:** Open plugged pores with a dark surface.
- **Papules:** Small red, tender bumps.
- **Pustules:** Pimples with pus at their tips.
- **Nodules:** Large, solid, painful lumps beneath the surface.
- **Cysts:** Painful, pus-filled lumps beneath the surface that can cause scarring.
**Treatment:**
Treatment depends on the severity and type of acne but may include:
- **Topical Treatments:** Such as benzoyl peroxide, salicylic acid, or retinoids to reduce bacteria and unclog pores.
- **Oral Medications:** Antibiotics or oral contraceptives for hormonal acne.
- **Procedures:** Such as chemical peels, extraction of comedones, or light therapy for more severe cases.
**Prevention and Management:**
- **Cleanse:** Regularly wash skin with a gentle cleanser.
- **Moisturize:** Use non-comedogenic moisturizers to keep skin hydrated without clogging pores.
- **Avoid Irritants:** Such as harsh cosmetics or excessive scrubbing.
- **Sun Protection:** Use sunscreen to prevent exacerbation of acne scars and inflammation.
Acne treatment can take time, and consistency in skincare routines and treatments is crucial. Consulting a dermatologist can help tailor a treatment plan that suits individual needs and reduces the risk of scarring or long-term skin damage.
Congestive Heart failure is caused by low cardiac output and high sympathetic discharge. Diuretics reduce preload, ACE inhibitors lower afterload, beta blockers reduce sympathetic activity, and digitalis has inotropic effects. Newer medications target vasodilation and myosin activation to improve heart efficiency while lowering energy requirements. Combination therapy, following an assessment of cardiac function and volume status, is the most effective strategy to heart failure care.
As the world population is aging, Health tourism has become vitally important and will be increased day by day. Because
of the availability of quality health services and more favorable prices as well as to shorten the waiting list for medical
services regionally and internationally. There are some aspects of managing and doing marketing activities in order for
medical tourism to be feasible, in a region called as clustering in a region with main stakeholders groups includes Health
providers, Tourism cluster, etc. There are some related and affecting factors to be considered for the feasibility of medical
tourism within this study such as competitiveness, clustering, Entrepreneurship, SMEs. One of the growth phenomenon
is Health tourism in the city of Izmir and Turkey. The model of five competitive forces of Porter and The Diamond model
that is an economical model that shows the four main factors that affect the competitiveness of a nation and its industries
in this study. The short literature of medical tourism and regional clustering have been mentioned.
- Video recording of this lecture in English language: https://youtu.be/RvdYsTzgQq8
- Video recording of this lecture in Arabic language: https://youtu.be/ECILGWtgZko
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
BBB and BCF
control the entry of compounds into the brain and
regulate brain homeostasis.
restricts access to brain cells of blood–borne compounds and
facilitates nutrients essential for normal metabolism to reach brain cells
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)GeorgeKieling1
Home
Organization
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
About AOMA: The Academy of Oriental Medicine at Austin offers a masters-level graduate program in acupuncture and Oriental medicine, preparing its students for careers as skilled, professional practitioners. AOMA is known for its internationally recognized faculty, award-winning student clinical internship program, and herbal medicine program. Since its founding in 1993, AOMA has grown rapidly in size and reputation, drawing students from around the nation and faculty from around the world. AOMA also conducts more than 20,000 patient visits annually in its student and professional clinics. AOMA collaborates with Western healthcare institutions including the Seton Family of Hospitals, and gives back to the community through partnerships with nonprofit organizations and by providing free and reduced price treatments to people who cannot afford them. The Academy of Oriental Medicine at Austin is located at 2700 West Anderson Lane. AOMA also serves patients and retail customers at its south Austin location, 4701 West Gate Blvd. For more information see www.aoma.edu or call 512-492-303434.
3. Fetal Circulation
• The key features of fetal circulation are shown in Figure and listed
below:
• 1. Low systemic vascular resistance (SVR) secondary to the low-
resistance placenta
• 2. High PVR secondary to fluid-filled lungs and a hypoxic
environment
• 3. Minimal pulmonary blood flow and low left atrial pressure
4. High pulmonary artery pressure
•
5. The most oxygenated blood from the umbilical vein perfuses the
brain and heart, bypassing the liver via the ductus venosus and
bypassing the right ventricle via the foramen ovale.
•
6. High PVR forces most right ventricular output across the ductus
arteriosus into the descending aorta, allowing deoxygenated blood to
return to the placenta.
4. Transitional Circulation-Changes at
Birth
• Cord clamping initiates breathing and causes
inflation of lungs with air which in turn causes
changes in resistances within the system. Cord
clamping also removes the low resistance
placenta from the circulation and so increase
SVR.
• Increased oxygen tension in lungs causes PVR
to decrease
• On cord clamping flow through ductus venosus
ceases. Permanent closure of ductus arteriosus
takes weeks
5. Fetal Circulation
– Not in series as in
adults
– Right heart dominant
(65% CO from RV;
35% from LV)
– Lung flow 8%, Brain
20%, Coronaries 3%
– Fetal heart pumps
55% BV through the
placenta and acts as
fetal lung
6.
7. Normal Values of Intracardiac Cardiac and Vascular
Pressures (in mm Hg)
Location
Term Newborns Infants and Children
Right atrium m = 0-4
a = 5-10
v = 4-8
m = 2-6
Right ventricle 35-50/1-5 15-25/2-5
Pulmonary artery
35-80/20-50
m = 25-60
15-25/8-12
10-6
Pulmonary wedge m = 3-6
a = 6-12
v = 8-15
m = 5-10
Left atrium m = 3-6
a = 6-12
v = 8-15
m = 5-10
Left ventricle 80-130/5-10
Systemic artery
65-80/45-60
m = 60-65
90-130/60-80
m = 70-95
8. Congenital Heart Diseases
• #1 cause of common congenital diseases (30%)
• Diagnosed by fetal US or echo if suspected after
birth (50% diagnosed during 1st week of life, the
rest before age 5)
• S/s: dyspnea, slow physical development (FTT),
cardiac murmur
• Chromosomal abnormalities- 10% congenital
(trisomy 21)
• 90% are genetic with or without external factors
(rubella, ETOH abuse, lithium, maternal DM)
9.
10. Classification of Congenital Heart
Diseases
Acyanotic Defects (L to R
shunts)
• VSD
• ASD
• PDA
• Pul stenosis
• Aortic Stenosis
• CoA
• Atrioventricular septal
defect
Cyanotic Defects (R to L
shunts): 5 T’s
• TOF
• Transposition of Great
Vessels
• Truncus Arteriosus
• Tricuspid Atresia
• Total Anomalous
Pulmonary Venous
Return
• HLHS
11. Classification of Congenital Heart Lesions and Associated Repairs
Lesion Type Repair
Shunt Lesions
Left-to-Right
• Atrial septal defects Complete repair
• Ventricular septal defects Complete repair
• Atrioventricular canal defects Complete repair
• Patent ductus arteriosus Complete repair
• Aortopulmonary window Complete repair
Right-to-Left
• Tetralogy of Fallot Complete repair
• Ebstein's anomaly Complete repair
• Pulmonary stenosis in conjunction with atrial
or ventricular septal defects Complete repair
• Eisenmenger's syndrome No repair
Transposition Physiology
• Dextro-transposition of the great arteries Complete repair
Single-Ventricle Physiology
One-Ventricle Lesions
• Hypoplastic left heart syndrome Staging to Fontan
• Tricuspid atresia Staging to Fontan
• Double inlet left ventricle Staging to Fontan
Two-Ventricle Lesions
• Truncus arteriosus Complete repair
• Tetralogy of Fallot with pulmonary atresia Complete repair
• Severe neonatal aortic stenosis Complete repair
13. Factors Influencing Outcome and
Anesthetic Risk
• Defect and type of repair
• Shunting
• Ventricular dysfunction
• Ventricular outflow obstruction
• Hypoxemia and cyanosis
•
Rhythm and conduction abnormalities
• Pulmonary hypertension and Eisenmenger's syndrome
• Myocardial ischemia
• Infective endocarditis
• End-organ dysfunction and injury
• Extracardiac anomalies
• Heart transplant recipients
14. Defect and Type of Repair
• Anatomic repair – morphologic left ventricle is
connected to the aorta, and morphologic right
ventricle is connected to the pulmonary artery,
the circulation is in series, cyanosis is corrected
• Physiologic repair- the heart is either
univentricular or biventricular with the
morphologic right ventricle being systemic
ventricle and morphologic left ventricle being
pulmonary ventricle, circulation is in series and
cyanosis is relieved
15. Anesthetic Considerations
• Simple anatomic repair- near normal
hemodynamics with structurally normal heart
• Complex anatomic repair- pose more
anesthetic risk
• Physiologic repair- always palliative, associated
with progressive ventricular dysfunction
16. Shunting
• Physiology-oxygenated blood to lungs with L to
R shunt and deoxygenated blood to systemic
circulation with R to L shunt
• Factors influencing degree and direction of
shunting- size of shunt orifice, pressure
gradient between chambers, relative
compliance of ventricles, ratio of PVR
/SVR,blood viscosity
17. Anesthetic Considerations
• Avoidance of air bubbles to prevent
systemic embolization
• Attention to pulmonary vascular tone and
its influence on PVR/SVR.
18. Ventricular dysfunction
• Most common cause of disability and
death in patients with CHD
• Ventricular volume overload secondary to
L to R shunt,valvular regurgitation and
single ventricle lesions
• Ventricular pressure overload secondary
to ventricular outflow obstruction
,increased PVR
19. Anesthetic considerations
• Carefully integrate historical, physical and
diagnostic test to judge the degree of ventricular
dysfunction
• Consider prophylactic inotrope perioperatively
• Appropriate fluid administration
• Suitable anesthetic techniques to maintain
contractility and hemodynamics
• Positive pressure ventilation improves function
of dysfunctional systemic ventricle by decreasing
afterload
20. Ventricular outflow obstruction
• May be subvalvar,valvar or supravalvar
• Results in a stiff ventricle(diastolic
dysfunction) and ultimately systolic
ventricular dysfunction
• LV obstruction-AS,Coarctation,variants of
HLHS
• RV obstruction-PS,TOF,Secondary to RV
to PA conduits,Rastelli procedure
21. Anesthetic considerations
• Pressure overload increases risk of
ischemia
• Maintaining sinus rhythm and preload is
vital to maintain CO
• Careful choice of induction and
maintenance agents i.e. inhaled agents vs.
narcotics
22. Hypoxemia and Cyanosis
• ETIOLOGY-Cyanotic lesions include
tricuspid atresia,TOF,TGA,Truncus
arteriosus,low cardiac output states
,increased a-v oxygen difference and
respiratory disease
• Chronic hypoxemia-polycythemia-
increased blood viscosity-increase PVR
and SVR,thrombocytopenia
• Increased risk of stroke
23. Anesthetic Considerations
• Maintain adequate preoperative hydration
• Consider measures to reduce red cell
mass if Hgb more than 20g/dl
• Expect coagulopathic states
24. Rhythm and conduction
abnormalities
• May be secondary to injury to SA node,AV node,
conduction system,atrial or ventricular
scarring,chamber dilation or hypertrophy and
ischemia
• Anesthetic considerations
• Careful workup on new onset of palpitations or
syncope for elective surgery
• Careful preop check on pacemakers and AICDs
• Consider temporary pacing for significant
bradycardias
25. Pulmonary Hypertension
• Mean PAP greater than 25 mm of Hg
• Increase in PVR-increased RV afterload and decreased
RV stroke volume-RV dilation-left shift of interventricular
septum –impaired filling of LV and finally decreased CO
and leading to ischemia
• Anesthetic considerations
• Consider adequate preop sedation, high inspired
oxygen,hyperventilation,maintain normal to increased
preload, early use of inotrope and careful choice of
anesthetics to maintain contractility
• Endotracheal intubation a potential trigger to pulmonary
vasoreactivity,avoid PEEP, use NO, consider continuing
pulmonary vasodilatiors
26. Acyanotic Defects (L to R):
VSD
• Intracardiac left to
right shunt
• Increased pulmonary
blood flow
• CHF secondary to
systemic and
pulmonary vascular
congestion
• Usually no cyanosis
27. Acyanotic Defects (L to R):
VSD
• Compare
inhalation and
intravenous
induction
methods for left
to right shunt
28. Acyanotic Defects (L to R):
ASD
• May occur anywhere
in the atrial septum,
most as spont genetic
mutations
• May be assoc with
MVP or MR
• Direction and
magnitude of the
shunt are determined
by the size of the
defect
29. Acyanotic Defects (L to R):
AV Septal Defect
• ASD, VSD, A-V
valvular insufficiency
• L to R shunting at the
atrial and vent levels
• Pul and Syst HTN
• Some infants have
palliative PA banding
• Most have total
correction
30. Acyanotic Defects (L to R):
ASD
Anesth considerations:
• Careful attention to
SVR, PVR during
induction and
maintenance
• Prophylactic
antibiotics
• Avoid air in IVs
31. Acyanotic Defects (L to R):
VSD
• Most common
congenital anomaly
• Most spontaneously
close by 2 years (30-
40%)
• S/s: asymptomatic,
feeding difficulty,
deceased exercise
tolerance, fatigue,
frequent URIs, CHF,
Pul HTN
32. Acyanotic Defects (L to R):
VSD
Anesth considerations:
• Avoid increases in SVR and decreases in PVR.
Why? How would 100% oxygen affect the
balance?
• IV induction is preferred (ketamine/etomidate
+fentanyl) or very slow low concentrations of
inh agents
• LVH and limited cardiac reserve- potential for
myocardial depression with inh agents
• Potential for shunt reversal with induction;
cyanosis on induction is confirmation
33. Acyanotic Defects (L to R):
PDA
• Continous flow of oxy
rich blood to the PA
• Detected during PE
• Most are
asymptomatic
• Uncorrected lesions
lead to CHF, Pul HTN
• 70% preterm infants
will require surgical
ligation
34. Acyanotic Defects (L to R):
PDA
• Ligation can be
performed in NICU
with a small left
thoracotomy incision
without CPB
• Risks: ICH, blood
loss, ligation of wrong
vessels, infections,
RLN damage
35. Acyanotic Defects (L to R):
PDA
Medical management:
• Cox inhibitors (indomethacin, ibuprofen)
inhibit prostaglandin synthesis
36. Acyanotic Defects (L to R):
CoA
• Narrowing of the aortic
lumen distal to the left SV
artery
• In older kids-post ductal
• In infants- pre ductal
• May occur with other
anomalies: bicuspid AV,
PDA, VSD, Turner
syndrome, MS or MR,
aneurysms of the circle of
Willis
37. Acyanotic Defects (L to R):
CoA
• Systemic circulation depends on shunting
• Medical management: PGE1 infused at
0.1mcg/kg/min to reopen the DA until the
severity of the CoA is assessed with echo
or cardiac MRI
• Surgical management: resection of the
CoA; balloon dilatation
38. Acyanotic Defects (L to R):
CoA
Anesth considerations:
• Maintain adequate
perfusion to the LE during
cross-clamping of the
aorta
• Aline in the right radial
artery (WHY?) and
femoral aline (where?)
• Gradient can be >40
mmHg
39. SINGLE VENTRICLE
PHYSIOLOGY
• Definition: presence of two atrioventricular valves with
one ventricular chamber
• Pathophysiology-Complex mixing of systemic and
pulmonary venous blood at atrial or ventricular level
• Correction involves three phases
I) Optimization of oxygen delivery and perfusion pressure
II) Reducing volume load on ventricle (glenn procedure)
III) Achieving series circulation with fully saturated
systemic arterial blood(fontan procedure)
40. Cyanotic Defects (R to L):
Teratology of Fallot
• What are the 4
components?
42. Cyanotic Defects (R to L):
Teratology of Fallot
• “Tet” spells:
hypercyanosis period
associated with
hyperventilation and
syncope due to exertion
and drop in SVR
• Tet spell treatment:
prone, knee-chest
position, squatting,
supplemental O2,
morphine, propranolol,
phenylephrine
43. Cyanotic Defects (R to L):
Teratology of Fallot: Pre-op
• Hydrate prior to OR arrival
• Crying can precipitate hypercyanotic
attack
• Continue B-blockers
44. Cyanotic Defects (R to L):
Hypoplastic Left Heart Syndrome
• Uniformly lethal cardiac abnormality if not
surgically corrected
• Norwood procedure (stage I), the hemi-
Fontan or bidirectional Glenn procedure
(stage II), and the Fontan procedure
(stage III).
45. Cyanotic Defects (R to L):
Hypoplastic Left Heart Syndrome
• Norwood procedure (stage I)
first weeks of life
(1) creating an anastomosis
between the main pulmonary
artery and the aorta to provide
systemic blood flow
(2) placing an aorta–to–
pulmonary artery shunt (BTS) to
provide pulmonary circulation
(3) performing an atrial
septectomy to provide
unrestricted blood flow across the
atrial septum
.
46. Cyanotic Defects (R to L):
Hypoplastic Left Heart Syndrome
• Hemi-Fontan procedure (stage II) 6
months
(1) creating an anastomosis between
the superior vena cava and the right
pulmonary artery, so that venous
return from the upper body can flow
directly into both lungs.
(2) The aorta–to–pulmonary artery
shunt that was placed at stage I is
ligated.
(3) The superior vena cava–right
atrial junction is closed with a patch
that is removed during the next stage.
Blood from the inferior vena cava
continues to drain into the right atrium.
47. Cyanotic Defects (R to L):
Hypoplastic Left Heart Syndrome
• Fontan procedure (stage III) 12
months
(1) Atrial patch is removed
(2) A wall (baffle) is built in the
right upper chamber. The baffle
guides the blue blood to the
pulmonary arteries
(3) Small holes (fenestration) are
made in the baffle. This allows a
small amount of blue blood to go
across the baffle into the atria.
This hole works like a pop-off
valve in case the pressure in the
lungs gets too high.
48. Symptoms of significant CHF in
Infants
• Respiratory-
Tachypnea,Grunting,Flaring,Retractions,P
ulmonary congestion on chest x’ray
• Growth and Nutrition-
Poor feeding,Poor growth,Failure to thrive
• Cardiovascular-
Tachcardia,Diminished pulses,Decreased
peripheral perfusion,hepatomegaly
50. ASD
Physiology – L to R shunt
Unrepaired- small to moderate defects well tolerated,A fib, Risk
of paradoxical emboli, large defects lead to arrhythmias, poor
exercise tolerance and rarely PHT
*Anesthetic consideration: De air IV line
VSD
Physiology
Unrepaired-large defects lead to PHT,Small to moderate defects
risk of endocarditis,sub-pulmonic or sub-aortic obstruction,
aortic regurgitation, right ventricular failure
*Anesthetic consideration: manage L to R shunt, or R to L shunt
Repaired-complete heart block,persitent PHT,dysrhythmia
*Anesthetic consideration: Manage pacemaker
51. • COARCTATION OF AORTA
Physiology-LV pressure overload and
hypertrophy,Aortic branch collaterals,
Association with biscuspid aortic valve(50-
80%),Endothelial dysfunction
Problems: Blood pressure gradient between
upper and lower limbs, Systemic hypertension,
Aneurysms of ascending and descending aorta,
Premature CAD, Intracranial aneurysms
*Anesthetic consideration: Inaccurate blood
pressure with previous subclavian
angiolplasty,post op hypertension, Avoid
tachycardia and hypotension
52. • TETRALOGY OF FALLOT
Unrepaired-R to L shunt, Cyanosis,
Anesthetic consideration: Avoid
tachycardia,hypovolemia ,increased contractility
Palliated-Blalock-Taussig shunt-chronic LV
overload,+/- cyanosis, Pulmonary HTN
Anesthetic consideration: Maintain pulmonary
blood flow, maintain systemic blood pressure
Repaired-Sinus and A-V node dysfunction,
PHT,Residual VSD,LV RV dysfunction
Anesthetic consideration: Detect and manage
dysrhythmias,manage pacemaker
54. Transplanted Heart
• Autonomically mediated responses are absent
i.e.vagal slowing,baroreceptor induced blood
pressure changes
• Cardiac output is dependent on venous return &
circulating catecholamines
• Changes in HR as index of light anesthesia or
hypovolemia are unreliable
• Cardiac drugs exert direct effects only-
epinephrine,norepinephrine,dopamine and
isoproterenol
• Hypovolemia is poorly tolerated